购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • Antibacterial
    (2)
  • Antibiotic
    (2)
  • NF-κB
    (2)
  • COX
    (1)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (2)
  • 35日内发货
    (1)
  • 8-10周
    (1)
抑制剂&激动剂
细分筛选
搜索结果
TargetMol产品目录中 "4-aminosalicylic acid"的结果
筛选
搜索结果
TargetMol产品目录中 "

4-aminosalicylic acid

"的结果
  • 抑制剂&激动剂
    4
    TargetMol | Inhibitors_Agonists
  • 4-Aminosalicylic acid
    对氨水杨酸, para-aminosalicylic acid, Aminosalicylic acid, Aminopar
    T129665-49-6
    4-Aminosalicylic acid (para-aminosalicylic acid) 是一种具有口服活性的抗生素,可研究肺结核病。
    • ¥ 99
    In stock
    规格
    数量
  • 4-Aminosalicylic acid hemicalcium
    T79916133-15-3
    4-Aminosalicylic acid hemicalcium 是一种具有口服活性的抗结核药物,主要用于治疗肺结核。
    • 待询
    8-10周
    规格
    数量
  • Sodium 4-aminosalicylate dihydrate
    对氨基水杨酸钠二水合物, Sodium 4-Aminosalicylate, 4-Amino-salicylic acid sodium salt
    T00206018-19-5
    Sodium 4-aminosalicylate dihydrate (4-Amino-salicylic acid sodium salt) 是一种抗耐药性结核化合物。
    • ¥ 99
    In stock
    规格
    数量
  • Olsalazine-13C6
    Olsalazine-13C6
    T36660
    Olsalazine-13C6is intended for use as an internal standard for the quantification of olsalazine by GC- or LC-MS. Olsalazine is an orally bioavailable prodrug form of the anti-inflammatory agent 5-aminosalicylic acid that is cleaved by bacterial azo reductases in the gut to generate active 5-ASA.1In vitro, olsalazine increases ion transport in isolated rabbit distal ileum when applied to the luminal side (ED50= 0.3 mM) and stimulates fluid transport in rat jejunum when used at a concentration of 5 mM.2,3Olsalazine (150 mg/kg for 8 days) improves stool consistency and decreases occult and gross bleeding as well as myeloperoxidase (MPO) activity and leukotriene B4levels in colon tissue in a mouse model of acute colitis induced by dextran sulfate .4Olsalazine also inhibits bovine xanthine oxidasein vitro(IC50= 3.4 mg/L) and lowers serum uric acid levels in a mouse model of hyperuricemia induced by oxonic acid when administered at a dose of 20 mg/kg.5Formulations containing olsalazine have been used in the treatment of inflammatory bowel disease (IBD) and ulcerative colitis. 1.Nugent, S.G., Kumar, D., Rampton, D.S., et al.Intestinal luminal pH in inflammatory bowel disease: Possible determinants and implications for therapy with aminosalicylates and other drugsGut48(4)571-577(2001) 2.Pamukcu, R., Hanauer, S.B., and Chang, E.B.Effect of disodium azodisalicylate on electrolyte transport in rabbit ileum and colon in vitro. Comparison with sulfasalazine and 5-aminosalicylic acidGastroenterology95(4)975-981(1988) 3.Mohsen, A.Q.M., Mulvey, D., Priddle, J.D., et al.Effects of olsalazine in the jejunum of the ratGut28(3)346-352(1987) 4.Murthy, S., Murthy, N.S., Coppola, D., et al.The efficacy of BAY y 1015 in dextran sulfate model of mouse colitisInflamm. Res.46(6)224-233(1997) 5.Niu, Y., Li, H., Gao, L., et al.Old drug, new indication: Olsalazine sodium reduced serum uric acid levels in mice via inhibiting xanthine oxidoreductase activityJ. Pharmacol. Sci.135(3)114-120(2017)
    • ¥ 11100
    35日内发货
    规格
    数量